CNSL stock news
This page provides real-time market news, earnings updates, and company announcements related to Cambridge Nutritional Sciences PLC (CNSL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-20 19:52 GMT
Cullinan Therapeutics: Fourth Quarter Earnings Overview
101 finance2026-03-10 11:33:38
IonQ: £1.675M Donation, 2.56M Shares Issued, $12.8B Valuation
101 finance2026-03-11 14:52:26
IonQ (IONQ) Shares Decline, Here's the Reason
101 finance2026-03-11 21:39:38
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Seres Therapeutics: Fourth Quarter Earnings Overview
101 finance2026-03-12 11:36:13
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
Finviz2026-03-12 12:33:48
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:50
Digital Convergence Technologies (DCT) Joins Akamai Partner Connect Program
Finviz2026-03-13 10:36:46
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-16 11:03:46
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Finviz2026-03-16 11:03:46
Black Diamond: Fourth Quarter Financial Results Overview
101 finance2026-03-16 20:27:45
An investor offloaded $104 million worth of Nuvalent shares as the cancer drug company surged almost 30%.
101 finance2026-03-17 00:33:09
LPL Financial Welcomes Consilium Wealth
Finviz2026-03-17 12:57:44
LPL’s Commonwealth merger is challenged by a wave of departing advisors and a $1 billion asset outflow—raising concerns that execution issues may undermine the consolidation strategy
101 finance2026-03-17 13:21:37
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Finviz2026-03-17 20:33:51
$IONQ: Sovereign Capital Meets a Technical Bottom
TradingView2026-03-17 20:45:18
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD)
Finviz2026-03-18 12:03:48
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
Finviz2026-03-18 12:33:43
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Finviz2026-03-18 20:09:49
IonQ's Quantum Gambit: $540M Volume (Rank 231) Marks Tug-of-War Between Explosive Growth and $510M Losses
101 finance2026-03-19 23:39:59
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
Finviz2026-03-20 12:33:48
Seres Therapeutics: Fourth Quarter Earnings Overview
101 finance2026-03-12 11:36:13
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
Finviz2026-03-12 12:33:48
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:50
Digital Convergence Technologies (DCT) Joins Akamai Partner Connect Program
Finviz2026-03-13 10:36:46
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-16 11:03:46
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Finviz2026-03-16 11:03:46
Black Diamond: Fourth Quarter Financial Results Overview
101 finance2026-03-16 20:27:45
An investor offloaded $104 million worth of Nuvalent shares as the cancer drug company surged almost 30%.
101 finance2026-03-17 00:33:09
LPL Financial Welcomes Consilium Wealth
Finviz2026-03-17 12:57:44
LPL’s Commonwealth merger is challenged by a wave of departing advisors and a $1 billion asset outflow—raising concerns that execution issues may undermine the consolidation strategy
101 finance2026-03-17 13:21:37
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
Finviz2026-03-17 20:33:51
$IONQ: Sovereign Capital Meets a Technical Bottom
TradingView2026-03-17 20:45:18
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD)
Finviz2026-03-18 12:03:48
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
Finviz2026-03-18 12:33:43
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Finviz2026-03-18 20:09:49
IonQ's Quantum Gambit: $540M Volume (Rank 231) Marks Tug-of-War Between Explosive Growth and $510M Losses
101 finance2026-03-19 23:39:59
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
Finviz2026-03-20 12:33:48
CNSL stock price change
On the last trading day, CNSL stock closed at 1.90 GBP, with a price change of 0.00% for the day.
Trade stock perpsCNSL stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more